World Leader in Genetic Risk Assessment

Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology.


Listed on the ASX(GTG) in 2000.

Listed on the NASDAQ (GENE) in 2005.

International R&D and commercialisation partner to:

  • universities

  • research organisations

  • progressive medical product distribution companies

Who we are

We are a molecular diagnostics company that offers predictive testing and assessment tools to empower physicians to proactively manage patient health

  • We empower individuals to manage and reduce their risk of contracting cancer and other chronic diseases

  • We strive to maintain our standing as a global leader in genomics

Our values


Proactive, striving, responsive and motivated


Punctual, trustworthy, accountable and respectful


Informative, receptive, transparent, cooperative


Dedicated, enthusiastic, energetic, inspiring